<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">r-n-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский неврологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian neurological journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2658-7947</issn><issn pub-type="epub">2686-7192</issn><publisher><publisher-name>МИА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2658-7947-2026-31-3-43-50</article-id><article-id custom-type="elpub" pub-id-type="custom">r-n-j-855</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ И КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL RESEARCHES AND CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Оценка устойчивости к гипоксии пациентов с болезнью Паркинсона</article-title><trans-title-group xml:lang="en"><trans-title>Assessment of hypoxia resistance in patients with Parkinson’s disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8659-9832</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гусева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Guseva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Томск</p></bio><bio xml:lang="en"><p>Tomsk</p></bio><email xlink:type="simple">guseva.ov@ssmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6547-6622</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жукова</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhukova</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Томск</p></bio><bio xml:lang="en"><p>Tomsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>31</day><month>08</month><year>2026</year></pub-date><volume>31</volume><issue>3</issue><fpage>43</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гусева О.В., Жукова Н.Г., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Гусева О.В., Жукова Н.Г.</copyright-holder><copyright-holder xml:lang="en">Guseva O.V., Zhukova N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.r-n-j.com/jour/article/view/855">https://www.r-n-j.com/jour/article/view/855</self-uri><abstract><p>Цель исследования — оценка устойчивости к гипоксии при болезни Паркинсона (БП), связь с демографическими факторами, тяжестью заболевания, физическим и функциональным состоянием.Материал и методы. В исследование включено 263 пациента с БП и 145 человек контрольной группы (КГ). Пациентам проводили оценку пробы Штанге для определения устойчивости к гипоксии, двигательной функции по шкале (MDS UPDRS) — часть III, силы кисти, теста «6-минутной ходьбы» (ТШХ), когнитивного статуса по шкале MOCA.Результаты. У пациентов с БП и в КГ устойчивость к гипоксии мужчин была больше, чем женщин, при этом показатели мужчин с БП и КГ не различались. Устойчивость к гипоксии пациенток с БП была меньше, чем в КГ и снижалась при повышении тяжести БП. Не получено связи устойчивости к гипоксии и возраста при БП и в КГ. Устойчивость к гипоксии женщин с БП была связана с силой кисти, ТШХ и показателем MOCA; у мужчин с БП — с силой кисти и показателем MOCA. У мужчин и женщин КГ подобных корреляций не получено.Заключение: установлена гендерная зависимость устойчивости к гипоксии — снижение у женщин с БП и КГ, больше выраженное при БП, обусловленное тяжестью заболевания, снижением физического и функционального статуса. Связь устойчивости к гипоксии с физическими и когнитивными характеристиками предопределяют выбор направления тренировок для коррекции сниженной устойчивости к гипоксии при БП.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study — an assessment of resistance to hypoxia in Parkinson’s disease (PD), relationship with demographic factors, severity of the disease, physical and functional state.Material and methods. The study included 263 patients with PD and 145 people in the control group (CG). Patients were assessed with Barge test to determine resistance to hypoxia, motor function of PD on the scale (MDS UPDRS) — part III, grip strength, the “6-minute walk” test, cognitive status on the MOCA scale.Results. In PD and in CG, men’s resistance to hypoxia was greater than that of women, while the indicators of men with PD and CG did not differ. The resistance to hypoxia in women with PD was less than KG and decreased with increasing severity of PD. The relationship of resistance to hypoxia in PD and CG with age has not been obtained. The resistance to hypoxia of women with PD was correlated with grip strength, “6-minute walk” test and the result of MOCA, while men’s strength was correlated with hand strength, which did not differ from CG, and the result of MOCA. No correlations were found of men and women in CG.Conclusion. Gender dependence of resistance to hypoxia has been established: the decrease in women with PD and in CG which is more pronounced in PD, due to decrease in physical and functional status. The interrelationships with the physical and cognitive levels determine the choice of training direction to correct the reduced resistance to hypoxia in PD.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>болезнь Паркинсона</kwd><kwd>гипоксия</kwd><kwd>тяжесть заболевания</kwd><kwd>возраст</kwd><kwd>пол</kwd><kwd>динамометрия</kwd><kwd>тест 6-минутной ходьбы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Parkinson’s disease</kwd><kwd>hypoxia</kwd><kwd>severity of the disease</kwd><kwd>age</kwd><kwd>gender</kwd><kwd>dynamometry</kwd><kwd>6-minute walk test</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gao Y, Zhang J, Tang T, Liu Z. Hypoxia Pathways in Parkinson’s Disease: From Pathogenesis to Therapeutic Targets. Int J Mol Sci. 2024;25(19):10484. https://doi.org/10.3390/ijms251910484</mixed-citation><mixed-citation xml:lang="en">Gao Y, Zhang J, Tang T, Liu Z. Hypoxia Pathways in Parkinson’s Disease: From Pathogenesis to Therapeutic Targets. Int J Mol Sci. 2024;25(19):10484. https://doi.org/10.3390/ijms251910484</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pinky, Neha, Salman M, Kumar P, Khan MA, Jamal A, Parvez S. Age-related pathophysiological alterations in molecular stress markers and key modulators of hypoxia. Ageing Res Rev. 2023;90:102022. https://doi.org/10.1016/j.arr.2023.102022</mixed-citation><mixed-citation xml:lang="en">Pinky, Neha, Salman M, Kumar P, Khan MA, Jamal A, Parvez S. Age-related pathophysiological alterations in molecular stress markers and key modulators of hypoxia. Ageing Res Rev. 2023;90:102022. https://doi.org/10.1016/j.arr.2023.102022</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Park K, Yang KI. Delayed parkinsonism following high mountain climbing: A case report. Neurol. Asia. 2013;18:99–10. http://www.neurology-asia.org/articles/neuroasia-2013-18(1)-099.pdf. Дата доступа 29.10.2025</mixed-citation><mixed-citation xml:lang="en">Park K, Yang KI. Delayed parkinsonism following high mountain climbing: A case report. Neurol. Asia. 2013;18:99–10. http://www.neurology-asia.org/articles/neuroasia-2013-18(1)-099.pdf. Дата доступа 29.10.2025</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pacelli С, Giguère N, Bourque MG, Lévesque M, Slack RS, Trudeau LE. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. Current Biology.2015;25(8):2349–2360. https://doi.org/10.1016/j.cub.2015.07.050</mixed-citation><mixed-citation xml:lang="en">Pacelli С, Giguère N, Bourque MG, Lévesque M, Slack RS, Trudeau LE. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. Current Biology.2015;25(8):2349–2360. https://doi.org/10.1016/j.cub.2015.07.050</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Burtscher J, Duderstadt Y, Gatterer H, Burtscher M, Vozdek R, Millet GP, Hicks AA, Ehrenreich H, Kopp M. Hypoxia Sensing and Responses in Parkinson’s Disease. Int J Mol Sci. 2024;25(3):1759. https://doi.org/10.3390/ijms25031759</mixed-citation><mixed-citation xml:lang="en">Burtscher J, Duderstadt Y, Gatterer H, Burtscher M, Vozdek R, Millet GP, Hicks AA, Ehrenreich H, Kopp M. Hypoxia Sensing and Responses in Parkinson’s Disease. Int J Mol Sci. 2024;25(3):1759. https://doi.org/10.3390/ijms25031759</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sun HL, Sun BL, Chen DW, Chen Y, Li WW, Xu MY, Shen YY, Xu ZQ, Wang YJ, Bu XL. Plasma α-synuclein levels are increased in patients with obstructive sleep apnea syndrome. Ann Clin Transl Neurol. 2019;6(4):788–794. https://doi.org/10.1002/acn3.756</mixed-citation><mixed-citation xml:lang="en">Sun HL, Sun BL, Chen DW, Chen Y, Li WW, Xu MY, Shen YY, Xu ZQ, Wang YJ, Bu XL. Plasma α-synuclein levels are increased in patients with obstructive sleep apnea syndrome. Ann Clin Transl Neurol. 2019;6(4):788–794. https://doi.org/10.1002/acn3.756</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Serebrovskaya T, Karaban I, Mankovskaya I, Bernardi L, Passino C, Appenzeller O. Hypoxic ventilatory responses and gas exchange in patients with Parkinson’s disease. Respiration. 1998;65(1):28–33. https://doi.org/10.1159/000029224</mixed-citation><mixed-citation xml:lang="en">Serebrovskaya T, Karaban I, Mankovskaya I, Bernardi L, Passino C, Appenzeller O. Hypoxic ventilatory responses and gas exchange in patients with Parkinson’s disease. Respiration. 1998;65(1):28–33. https://doi.org/10.1159/000029224</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Janssen Daalen JM, Meinders MJ, Mathur S, van Hees HWH, Ainslie PN, Thijssen DHJ, Bloem BR. Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol. BMC Neurol. 2024;24(1):212 https://doi.org/10.1186/s12883-024-03702-3</mixed-citation><mixed-citation xml:lang="en">Janssen Daalen JM, Meinders MJ, Mathur S, van Hees HWH, Ainslie PN, Thijssen DHJ, Bloem BR. Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocol. BMC Neurol. 2024;24(1):212 https://doi.org/10.1186/s12883-024-03702-3</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Potteti HR, Noone PM, Tamatam CR, Ankireddy A, Noel S, Rabb H, Reddy SP. Nrf2 mediates hypoxia-inducible HIF1α activation in kidney tubular epithelial cells. Am J Physiol Renal Physiol. 2021;320(3):F464-F474. https://doi.org/10.1152/ajprenal.00501.2020</mixed-citation><mixed-citation xml:lang="en">Potteti HR, Noone PM, Tamatam CR, Ankireddy A, Noel S, Rabb H, Reddy SP. Nrf2 mediates hypoxia-inducible HIF1α activation in kidney tubular epithelial cells. Am J Physiol Renal Physiol. 2021;320(3):F464-F474. https://doi.org/10.1152/ajprenal.00501.2020</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Choi YK. Detrimental Roles of Hypoxia-Inducible Factor-1α in Severe Hypoxic Brain Diseases. Int J Mol Sci. 2024;25(8):4465. https://doi.org/10.3390/ijms25084465</mixed-citation><mixed-citation xml:lang="en">Choi YK. Detrimental Roles of Hypoxia-Inducible Factor-1α in Severe Hypoxic Brain Diseases. Int J Mol Sci. 2024;25(8):4465. https://doi.org/10.3390/ijms25084465</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA. 2000;97(16):9082–7. https://doi.org/10.1073/pnas.97.16.9082</mixed-citation><mixed-citation xml:lang="en">Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA. 2000;97(16):9082–7. https://doi.org/10.1073/pnas.97.16.9082</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Burtscher J, Citherlet T, Camacho-Cardenosa A, CamachoCardenosa M, Raberin A, Krumm B, Hohenauer E, Egg M, Lichtblau M, Müller J, Rybnikova EA, Gatterer H, Debevec T, Baillieul S, Manferdelli G, Behrendt T, Schega L, Ehrenreich H, Millet GP, Gassmann M, Schwarzer C, Glazachev O, Girard O, Lalande S, Hamlin M, Samaja M, Hüfner K, Burtscher M, Panza G, Mallet RT. Mechanisms underlying the health benefi ts of intermittent hypoxia conditioning. J Physiol. 2024;602(21):5757–5783. https://doi.org/10.1113/JP285230</mixed-citation><mixed-citation xml:lang="en">Burtscher J, Citherlet T, Camacho-Cardenosa A, CamachoCardenosa M, Raberin A, Krumm B, Hohenauer E, Egg M, Lichtblau M, Müller J, Rybnikova EA, Gatterer H, Debevec T, Baillieul S, Manferdelli G, Behrendt T, Schega L, Ehrenreich H, Millet GP, Gassmann M, Schwarzer C, Glazachev O, Girard O, Lalande S, Hamlin M, Samaja M, Hüfner K, Burtscher M, Panza G, Mallet RT. Mechanisms underlying the health benefi ts of intermittent hypoxia conditioning. J Physiol. 2024;602(21):5757–5783. https://doi.org/10.1113/JP285230</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wakhloo D, Scharkowski F, Curto Y, Javed Butt U, Bansal V, Steixner -Kumar AA, Wüstefeld L, Rajput A, Arinrad S, Zillmann MR, Seelbach A, Hassouna I, Schneider K, Qadir Ibrahim A, Werner HB, Martens H, Miskowiak K, Wojcik SM, Bonn S, Nacher J, Nave KA, Ehrenreich H. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11(1):1313. https://doi.org/10.1038/s41467-020-15041-1</mixed-citation><mixed-citation xml:lang="en">Wakhloo D, Scharkowski F, Curto Y, Javed Butt U, Bansal V, Steixner -Kumar AA, Wüstefeld L, Rajput A, Arinrad S, Zillmann MR, Seelbach A, Hassouna I, Schneider K, Qadir Ibrahim A, Werner HB, Martens H, Miskowiak K, Wojcik SM, Bonn S, Nacher J, Nave KA, Ehrenreich H. Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin. Nat Commun. 2020;11(1):1313. https://doi.org/10.1038/s41467-020-15041-1</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Urakov AL, Urakova NA. Modifi ed Stange test gives new gynecological criteria and recommendations for choosing caesarean section childbirth. Bioimpacts. 2022;12(5):477–478. https://doi.org/10.34172/bi.2022.23995</mixed-citation><mixed-citation xml:lang="en">Urakov AL, Urakova NA. Modifi ed Stange test gives new gynecological criteria and recommendations for choosing caesarean section childbirth. Bioimpacts. 2022;12(5):477–478. https://doi.org/10.34172/bi.2022.23995</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li CH, Chen WC, Liao WC, Tu CY, Lin CL, Sung FC, Chen CH, Hsu WH. The association between chronic obstructive pulmonary disease and Parkinson’s disease: a nationwide populationbased retrospective cohort study. QJM. 2015;108(1):39–45. https://doi.org/10.1093/qjmed/hcu136</mixed-citation><mixed-citation xml:lang="en">Li CH, Chen WC, Liao WC, Tu CY, Lin CL, Sung FC, Chen CH, Hsu WH. The association between chronic obstructive pulmonary disease and Parkinson’s disease: a nationwide populationbased retrospective cohort study. QJM. 2015;108(1):39–45. https://doi.org/10.1093/qjmed/hcu136</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Xue L, Zhang Y, Xie A. Association Between Stroke and Parkinson’s Disease: a Meta-analysis. J Mol Neurosci. 2020;70(8):1169–1176. https://doi.org/10.1007/s12031-020-01524-9</mixed-citation><mixed-citation xml:lang="en">Liu Y, Xue L, Zhang Y, Xie A. Association Between Stroke and Parkinson’s Disease: a Meta-analysis. J Mol Neurosci. 2020;70(8):1169–1176. https://doi.org/10.1007/s12031-020-01524-9</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Олимпийское руководство по спортивной медицине. Под ред. Уайба ВВ. Издательство Практика; 2011, 671 c. [Olympic textbook of medicine in sport. Edited by Uayba VV. Publishing house Praktika; 2011, 671 p. (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Олимпийское руководство по спортивной медицине. Под ред. Уайба ВВ. Издательство Практика; 2011, 671 c. [Olympic textbook of medicine in sport. Edited by Uayba VV. Publishing house Praktika; 2011, 671 p. (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Maioli S, Leander K, Nilsson P, Nalvarte I. Estrogen receptors and the aging brain. Essays Biochem. 2021;65(6):913–925. https://doi.org/10.1042/EBC20200162</mixed-citation><mixed-citation xml:lang="en">Maioli S, Leander K, Nilsson P, Nalvarte I. Estrogen receptors and the aging brain. Essays Biochem. 2021;65(6):913–925. https://doi.org/10.1042/EBC20200162</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Frost RA, Lang CH. Regulation of insulin-like growth factorI in skeletal muscle and muscle cells. Minerva Endocrinol. 2003;28(1):53–73.</mixed-citation><mixed-citation xml:lang="en">Frost RA, Lang CH. Regulation of insulin-like growth factorI in skeletal muscle and muscle cells. Minerva Endocrinol. 2003;28(1):53–73.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Goldspink G, Harridge SD. Growth factors and muscle ageing. Exp Gerontol. 2004;39(10):1433–8. https://doi.org/10.1016/j.exger.2004.08.010</mixed-citation><mixed-citation xml:lang="en">Goldspink G, Harridge SD. Growth factors and muscle ageing. Exp Gerontol. 2004;39(10):1433–8. https://doi.org/10.1016/j.exger.2004.08.010</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">David FJ, Raff erty MR, Robichaud JA, Prodoehl J, Kohrt WM, Vaillancourt DE, Corcos DM. Progressive resistance exercise and Parkinson’s disease: a review of potential mechanisms. Parkinsons Dis. 2012;2012:124527. doi: 10.1155/2012/124527</mixed-citation><mixed-citation xml:lang="en">David FJ, Raff erty MR, Robichaud JA, Prodoehl J, Kohrt WM, Vaillancourt DE, Corcos DM. Progressive resistance exercise and Parkinson’s disease: a review of potential mechanisms. Parkinsons Dis. 2012;2012:124527. doi: 10.1155/2012/124527</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Alley DE, Shardell MD, Peters KW, McLean RR, DamT-TL, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Studenski SA, Vassileva MT, Cawthont PM. Grip strength cutpoints for the identifi cation of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014;69(5):559–66. https://doi.org/10.1093/gerona/glu011</mixed-citation><mixed-citation xml:lang="en">Alley DE, Shardell MD, Peters KW, McLean RR, DamT-TL, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Studenski SA, Vassileva MT, Cawthont PM. Grip strength cutpoints for the identifi cation of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014;69(5):559–66. https://doi.org/10.1093/gerona/glu011</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
